You searched for "therapeutics"

406 results found

Latest NHS plan to modernise primary care misses an opportunity

Government announces drive to digitise GP phonelines and offer greater options in patient access to care in dentistry and pharmacy, but does not capitalise on opportunities to improve patient experiences closer to home or address IT connectivity issues holding back optometry services.

Researchers identify a novel genetic cause of Fuchs endothelial corneal dystrophy

Researchers identify a novel genetic cause of Fuchs endothelial corneal dystrophy, offering new ways for future therapies to target this common, age-related cause of visual loss. In a landmark study, researchers supported by NIHR Moorfields Biomedical Research Centre, have identified...

Moorfields Education: The macula course June 2026

Moorfields Education: The macula course

Is thrombolytic treatment warranted for central retinal artery occlusion?

Central retinal artery occlusion (CRAO) is a subtype of acute ischaemic stroke which results in severe visual loss. Acute CRAO is equivalent to a brain acute ischaemic stroke (AIS), as the obstruction of the central retinal artery (CRA) causes end-organ...

Current and emerging strategies for myopia control

This is a review of the current literature and strategies for myopia control. It discusses the epidemiology of myopia, the classification of myopia and the current treatment strategies. It presents data from landmark papers while discussing treatment strategies which they...

Bosch-Boonstro-Schaaff optic atrophy syndrome (BBSOAS) NR2F1 mutation

An experienced ophthalmologist can make an anatomical diagnosis of childhood visual impairment based upon the surgical sieve, i.e., congenital and acquired. But an ophthalmologist cannot work in isolation to make an aetiological diagnosis – one would require the help of...

Use of orthoK for myopia treatment

This article provides an updated literature review on the orthkeratology effect on myopia progression considering outcome measures, potential effect modifiers, mechanisms and current prescription concerns. The discussion centres on the extent of slowed myopia progression, mechanisms, safety concerns and comparisons...

A to Z of X-linked retinopathies

This review article provides an excellent summary of X-linked retinopathies and the corresponding genotype and clinical features. The authors provide a comprehensive overview of each condition in terms of its pathogenesis, clinical features, imaging findings, electrophysiology changes and any current...

Bacterial keratitis through the window of the known unknowns

This review article provides an up-to-date summary of current challenges in research and management of bacterial keratitis. The authors highlight that there is no current agreement on the criteria that should define bacterial keratitis; the role of investigation is unclear,...

In a new international eye study, nearly one in five patients report encountering bogus treatments

An international study, supported by NIHR Biomedical Research Centre: Moorfields, of almost 1,000 people living with sight loss, found that nearly one in five reported receiving or encountering eye treatments they believed to be ‘bogus’. The study raises concerns in...

Moorfields: The 2025 macula course

The 2025 Macula course will take place from 2nd - 5th June 2025. Bookings are now open. Retinal diseases are a major cause of blindness. Diagnostic investigations, understanding of disease mechanisms, new therapies, and the evidence base, have all evolved...

In conversation with Clare Abbott (ECLO)

Rosalyn Painter spoke to Clare Abbott, a member of the Eye Clinic Liaison Officer (ECLO) team at Oxford Eye Hospital, about her day-to-day job as an ECLO, how the role can help patients, and the ongoing importance of their work....